Newsletter, move beyond the basics in immuno-oncology

Preview text: Newsletter, move beyond the basics in immuno-oncology 96 Discover assays that measure more…

Wednesday, May 6, 2026 at 8:13 AM EasternHubSpot

Reaction BiologyNewsletter, move beyond the basics in immuno-oncology

Image not available

No image available for this email.

Subject: Newsletter, move beyond the basics in immuno-oncology
Preview text: Newsletter, move beyond the basics in immuno-oncology 96 Discover assays that measure more…
From: hello@marketing.reactionbiology.com
Brand: Reaction Biology
ESP: HubSpot
Sent: Wed May 6, 2026, 8:13 AM ET
Size: 80 KB
Images: 7
Links: 21, 2 of them buttons
Subject length: 53 characters

Against Reaction Biology's usual

Sent in its busiest hour, 8 AM, which holds 80% of its emails. The subject is 53 characters; its average is 58.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Reaction Biology <[email protected]>
Reply-To: [email protected]
Subject: Newsletter, move beyond the basics in immuno-oncology
Date: Wed, 6 May 2026 08:13:31 -0400
Message-ID domain: bf02x.hubspotemail.net
Return-Path domain: bf02x.hubspotemail.net
DKIM signature: d=bf02x.hubspotemail.net s=hs1; d=marketing.reactionbiology.com s=hs2-39973036
List-Unsubscribe: Present, one-click
Feedback-ID sender: HubSpot

from bid46ob.bf02x.hubspotemail.net [158.247.18.121] by our receiving server with ESMTPS

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

	Sep 10, 2026 8:33 AM	Complete characterization across activity, binding, and cellular assays
	Jul 21, 2026 9:16 AM	New Kinase Inhibitor Discoveries Powered by Gold-Standard Assay Formats
	May 13, 2026 2:57 PM	[Reaction Signals] Why Macrophage Phenotype Matters for IO Response
	May 6, 2026 8:13 AM	Newsletter, move beyond the basics in immuno-oncology (this email)
	Apr 8, 2026 8:10 AM	Enhance drug safety testing with proven solutions 🦺
	Apr 7, 2026 9:04 AM	NEW Publication and Webinar: 65,000 kinase-drug interactions mapped in new Nature Biotechnology study
	Apr 1, 2026 8:09 AM	Accelerate your ADC research with expert support